Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans

L Millet, H Vidal, F Andreelli, D Larrouy, J P Riou, D Ricquier, M Laville, D Langin, L Millet, H Vidal, F Andreelli, D Larrouy, J P Riou, D Ricquier, M Laville, D Langin

Abstract

Uncoupling protein-2 and -3 (UCP2 and UCP3) are mitochondrial proteins that show high sequence homology with the brown adipocyte-specific UCP1. UCP1 induces heat production by uncoupling respiration from ATP synthesis. UCP2 is widely expressed in human tissues, whereas UCP3 expression seems restricted to skeletal muscle, an important site of thermogenesis in humans. We have investigated the regulation of UCP2 and UCP3 gene expression in skeletal muscle and adipose tissue from lean and obese humans. UCP2 and -3 mRNA levels were not correlated with body mass index (BMI) in skeletal muscle, but a positive correlation (r = 0.55, P < 0.01, n = 22) was found between UCP2 mRNA level in adipose tissue and BMI. The effect of fasting was investigated in eight lean and six obese subjects maintained on a hypocaloric diet (1,045 kJ/d) for 5 d. Calorie restriction induced a similar 2-2.5-fold increase in UCP2 and -3 mRNA levels in lean and obese subjects. To study the effect of insulin on UCP gene expression, six lean and five obese subjects underwent a 3-h euglycemic hyperinsulinemic clamp. Insulin infusion did not modify UCP2 and -3 mRNA levels. In conclusion, the similar induction of gene expression observed during fasting in lean and obese subjects shows that there is no major alteration of UCP2 and -3 gene regulation in adipose tissue and skeletal muscle of obese subjects. The increase in UCP2 and -3 mRNA levels suggests a role for these proteins in the metabolic adaptation to fasting.

References

    1. J Clin Endocrinol Metab. 1997 Mar;82(3):739-44
    1. J Clin Invest. 1996 Jul 15;98(2):251-5
    1. Diabetes. 1997 May;46(5):900-6
    1. Nature. 1997 May 1;387(6628):90-4
    1. Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6386-90
    1. FEBS Lett. 1997 May 12;408(1):39-42
    1. Biochem Biophys Res Commun. 1997 Jun 9;235(1):79-82
    1. Biochem Biophys Res Commun. 1997 Jun 27;235(3):760-4
    1. Biochem Biophys Res Commun. 1997 Sep 18;238(2):606-11
    1. N Engl J Med. 1986 Jul 10;315(2):96-100
    1. Anal Biochem. 1987 Apr;162(1):156-9
    1. N Engl J Med. 1988 Feb 25;318(8):467-72
    1. FASEB J. 1990 Aug;4(11):2890-8
    1. J Clin Invest. 1990 Nov;86(5):1423-7
    1. FASEB J. 1991 Jun;5(9):2237-42
    1. Physiol Rev. 1996 Oct;76(4):1109-61
    1. Am J Physiol. 1996 Oct;271(4 Pt 1):C1380-9
    1. Nat Genet. 1997 Mar;15(3):269-72
    1. Int J Obes Relat Metab Disord. 1992 May;16(5):383-90
    1. Nature. 1993 Apr 15;362(6421):628-30
    1. Annu Rev Nutr. 1993;13:337-54
    1. Nature. 1993 Dec 23-30;366(6457):740-2
    1. N Engl J Med. 1995 Mar 9;332(10):621-8
    1. Nat Med. 1995 Nov;1(11):1155-61
    1. J Clin Invest. 1995 Dec;96(6):2914-23
    1. J Clin Invest. 1996 Jul 1;98(1):43-9
    1. Anal Biochem. 1997 Feb 15;245(2):141-8

Source: PubMed

3
Tilaa